Ph.D., Co-Founder and Chief Scientific Officer, Cardea Bio
Biography
Dr. Aran’s current research focuses on creating novel electronic biosensors with true multiomic detection capabilities and applying them to solve real-world problems. She invented CRISPR-ChipTM, which utilizes CRISPR and biology-gated transistors to create the only technology that rapidly detects genes of interest without amplification. CRISPR-Chip™ was the cover of Nature Biomedical Engineering in 2019, featured in over 50 news outlets, and the most read paper that year. CRISPR-Chip™ has since been expanded to detect single-point mutations - published in Nature Biomedical Engineering in 2021. Through Cardea Bio, Dr. Aran’s inventions are being actively developed into commercial products to ensure a lasting impact beyond the academic world. Her research efforts have been recognized by Clinical OMICs 10 under 40 Award, Athena Pinnacle Award, and Nature Research Awards for Inspiring Women in Science. Dr. Aran is also the recipient of numerous grants to develop the next generation of electronic biosensors, including the NSF CAREER Award and multiple NIH RO1 and DARPA grants.
Clinical & Research Tools Showcase:
Cardea Bio
Being able to use Biology as Technology will result in a new generation of natural resources and advanced Powered by Cardea products that have until now been impossible.
All-electronic Infrastructure Leads Way to Real-time Multiomics
A critical challenge faced by systems biology is that multiomics is crippled by the current optical and static approaches all requiring numerous systems. Our all-electronic system unifies multiomics through direct and real-time capture of interactive streams of actionable multiomic data.
Session Abstract – PMWC 2022 Silicon Valley
Track 1 - June 30 3.30 P.M.-4.30 P.M.
The last 10 years have been a breakout decade for CRISPR across research and medicine, and the next decade holds the potential for CRISPR to cure the underlying cause of genetic disease. This session will discuss the latest breakthroughs in the field and address the challenges that need to be overcome to deliver on the promise of CRISPR.
Session Abstract – PMWC 2022 Silicon Valley
Track 6 - June 28 4.00 P.M.-4.15 P.M.,Track 6 - June 29 9.00 A.M.-1.15 P.M.,Track 6 - June 30 1.45 P.M.-2.00 P.M.
The PMWC 2022 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.
